Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) EBT (2017 - 2026)

Rafael Holdings' (RFL) quarterly EBT came in at -$2.9 million in Q2 2026, up 55.38% year-over-year from -$1.9 million in Q2 2025, and up 53.97% quarter-over-quarter from -$6.3 million in Q1 2026.

Analysis

Rafael Holdings (RFL) EBT (2017 - 2026) Analysis & Trends

Rafael Holdings (RFL) has reported EBT for 10 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EBT rose 55.38% year-over-year to -$2.9 million in Q2 2026; TTM through Apr 2026 was -$31.2 million, a 20.23% decrease from a year earlier, with the FY2025 full-year figure at -$33.2 million, up 50.65% from the prior year.
  • EBT was -$2.9 million for Q2 2026 at Rafael Holdings, up from -$6.3 million in the prior quarter.
  • Over five years, EBT peaked at $6.1 million in Q1 2024 and troughed at -$64.9 million in Q2 2024.
  • A 5-year average of -$7.8 million and a median of -$5.0 million in 2022 frame the typical range for EBT.
  • The widest YoY moves for EBT: up 288.17% in 2024, down 3589.6% in 2024.
  • Over 5 years, EBT stood at -$5.2 million in 2022, then soared by 31.99% to -$3.5 million in 2023, then slumped by 160.03% to -$9.2 million in 2024, then fell by 6.52% to -$9.8 million in 2025, then soared by 70.41% to -$2.9 million in 2026.
  • The last three EBT figures came in at -$2.9 million (Q2 2026), -$6.3 million (Q1 2026), and -$9.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.77 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -10.25 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.39 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.53 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 542.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -767.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 177.81 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 132.40 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -294.56 Mn
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00 -2.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -2.90 Mn
Jan 31, 2026 -6.30 Mn
Oct 31, 2025 -9.80 Mn
Jul 31, 2025 -12.20 Mn
Apr 30, 2025 -6.50 Mn
Jan 31, 2025 -5.31 Mn
Oct 31, 2024 -9.20 Mn
Jul 31, 2024 -4.94 Mn
Apr 30, 2024 -64.90 Mn
Jan 31, 2024 6.11 Mn
Oct 31, 2023 -3.54 Mn
Jul 31, 2023 1.46 Mn
Apr 30, 2023 -1.76 Mn
Jan 31, 2023 -3.25 Mn
Oct 31, 2022 -5.20 Mn
Jul 31, 2022 -4.65 Mn
Apr 30, 2022 -4.98 Mn
Jan 31, 2022 -2.05 Mn
Oct 31, 2021 -128.29 Mn
Jul 31, 2021 -10.83 Mn